Autenrieth CS, Beck EJ, Stelzle D, Mallouris C, Mahy M, Ghys P. Global and regional trends of people living with HIV aged 50 and over: estimates and projections for 2000–2020. PLoS ONE. 2018;13(11):e0207005. https://doi.org/10.1371/journal.pone.0207005.
Article CAS PubMed PubMed Central Google Scholar
Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53(11):1120–6. https://doi.org/10.1093/cid/cir627.
Curno MJ, Rossi S, Hodges-Mameletzis I, Johnston R, Price MA, Heidari S. A systematic review of the inclusion (or Exclusion) of women in HIV Research: from Clinical studies of antiretrovirals and vaccines to cure strategies. J Acquir Immune Defic Syndr. 2016;71(2):181–8. https://doi.org/10.1097/QAI.0000000000000842.
Article CAS PubMed Google Scholar
Collins LF, Palella FJ Jr., Mehta CC, Holloway J, Stosor V, Lake JE, et al. Aging-related comorbidity Burden among women and men with or At-Risk for HIV in the US, 2008–2019. JAMA Netw Open. 2023;6(8):e2327584. https://doi.org/10.1001/jamanetworkopen.2023.27584.
Article PubMed PubMed Central Google Scholar
Bailin SS, Gabriel CL, Wanjalla CN, Koethe JR. Obesity and weight gain in persons with HIV. Curr HIV/AIDS Rep. 2020;17(2):138–50. https://doi.org/10.1007/s11904-020-00483-5.
Article PubMed PubMed Central Google Scholar
Giralt M, Domingo P, Guallar JP, Rodriguez de la Concepcion ML, Alegre M, Domingo JC, et al. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy. Antivir Ther. 2006;11(6):729–40.
Article CAS PubMed Google Scholar
Melchior JC, Salmon D, Rigaud D, Leport C, Bouvet E, Detruchis P, et al. Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr. 1991;53(2):437–41. https://doi.org/10.1093/ajcn/53.2.437.
Article CAS PubMed Google Scholar
Sax PE, Erlandson KM, Lake JE, McComsey GA, Orkin C, Esser S, et al. Weight Gain following initiation of antiretroviral therapy: risk factors in Randomized comparative clinical trials. Clin Infect Dis. 2020;71(6):1379–89. https://doi.org/10.1093/cid/ciz999.
Article CAS PubMed Google Scholar
Hernandez D, Kalichman S, Cherry C, Kalichman M, Washington C, Grebler T. Dietary intake and overweight and obesity among persons living with HIV in Atlanta Georgia. AIDS Care. 2017;29(6):767–71. https://doi.org/10.1080/09540121.2016.1238441.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (2019). Accessed July 16, 2020.
Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Med. 2016;17(4):255–68. https://doi.org/10.1111/hiv.12294.
Article CAS PubMed Google Scholar
Bares SH, Smeaton LM, Xu A, Godfrey C, McComsey GA. HIV-Infected women Gain more weight than HIV-Infected men following the initiation of antiretroviral therapy. J Womens Health (Larchmt). 2018;27(9):1162–9. https://doi.org/10.1089/jwh.2017.6717.
Andany N, Raboud JM, Walmsley S, Diong C, Rourke SB, Rueda S, et al. Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada. HIV Clin Trials. 2011;12(2):89–103. https://doi.org/10.1310/hct1202-89.
Bourgi K, Jenkins CA, Rebeiro PF, Palella F, Moore RD, Altoff KN, et al. Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020;23(4):e25484. https://doi.org/10.1002/jia2.25484.
Article PubMed PubMed Central Google Scholar
Chow W, Donga P, Cote-Sergent A, Rossi C, Lefebvre P, Lafeuille MH, et al. An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus. Curr Med Res Opin. 2020;36(8):1313–23. https://doi.org/10.1080/03007995.2020.1775074.
Article CAS PubMed Google Scholar
Group NAS, Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, et al. Dolutegravir-based or low-dose efavirenz-based regimen for the treatment of HIV-1. N Engl J Med. 2019;381(9):816–26. https://doi.org/10.1056/NEJMoa1904340.
Kileel EM, Lo J, Malvestutto C, Fitch KV, Zanni MV, Fichtenbaum CJ, et al. Assessment of obesity and cardiometabolic status by integrase inhibitor use in REPRIEVE: a propensity-weighted analysis of a multinational primary Cardiovascular Prevention Cohort of people with Human Immunodeficiency Virus. Open Forum Infect Dis. 2021;8(12):ofab537. https://doi.org/10.1093/ofid/ofab537.
Article CAS PubMed PubMed Central Google Scholar
Kileel EM, Malvestutto CD, Lo J, Fitch KV, Fichtenbaum CJ, Aberg JA, et al. Changes in body Mass Index with longer-term integrase inhibitor use: a longitudinal analysis of data from the Randomized Trial to prevent vascular events in human immunodeficiency virus (REPRIEVE). Clin Infect Dis. 2023;76(11):2010–3. https://doi.org/10.1093/cid/ciad107.
Article PubMed PubMed Central Google Scholar
Lake JE, Wu K, Bares SH, Debroy P, Godfrey C, Koethe JR, et al. Risk factors for Weight Gain following switch to integrase inhibitor-based antiretroviral therapy. Clin Infect Dis. 2020;71(9):e471–7. https://doi.org/10.1093/cid/ciaa177.
Article CAS PubMed PubMed Central Google Scholar
Menard A, Meddeb L, Tissot-Dupont H, Ravaux I, Dhiver C, Mokhtari S, et al. Dolutegravir and weight gain: an unexpected bothering side effect? AIDS. 2017;31(10):1499–500. https://doi.org/10.1097/QAD.0000000000001495.
Sokhela S, Venter WDF, Bosch B, Woods J, McCann K, Akpomiemie G, et al. Final 192-Week efficacy and safety results of the ADVANCE trial, comparing 3 first-line antiretroviral regimens. Open Forum Infect Dis. 2024;11(3):ofae007. https://doi.org/10.1093/ofid/ofae007.
Article PubMed PubMed Central Google Scholar
Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus two different prodrugs of Tenofovir to treat HIV. N Engl J Med. 2019;381(9):803–15. https://doi.org/10.1056/NEJMoa1902824.
Article CAS PubMed Google Scholar
Lahiri CD, Mehta CC, Yang Q, Maramba T, Musonge-Effoe J, Yang CA, et al. Short and long-term body weight change following the switch to or the addition of integrase inhibitors in persons with HIV differs by sex. Clin Infect Dis. 2024. https://doi.org/10.1093/cid/ciae474.
Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, et al. Changes in Waist circumference in HIV-Infected individuals initiating a raltegravir or protease inhibitor regimen: effects of Sex and Race. Open Forum Infect Dis. 2018;5(11):ofy201. https://doi.org/10.1093/ofid/ofy201.
Article CAS PubMed PubMed Central Google Scholar
Gregson CL, Madanhire T, Rehman A, Ferrand RA, Cappola AR, Tollman S, et al. Osteoporosis, rather than Sarcopenia, is the predominant Musculoskeletal Disease in a rural South African Community where human immunodeficiency virus prevalence is high: a cross-sectional study. J Bone Min Res. 2022;37(2):244–55. https://doi.org/10.1002/jbmr.4464.
Erlandson KM, Umbleja T, Lu MT, Taron J, Ribaudo HJ, Overton ET, et al. Associations of muscle density and area with coronary artery plaque and physical function. J Acquir Immune Defic Syndr. 2023;94(2):174–84. https://doi.org/10.1097/QAI.0000000000003244.
Article PubMed PubMed Central Google Scholar
Lake JE, Moser C, Johnston L, Magyar C, Nelson SD, Erlandson KM, et al. CT Fat Density accurately reflects histologic Fat Quality in adults with HIV On and off antiretroviral therapy. J Clin Endocrinol Metab. 2019;104(10):4857–64. https://doi.org/10.1210/jc.2018-02785.
Article PubMed PubMed Central Google Scholar
Scully EP. Sex differences in HIV infection. Curr HIV/AIDS Rep. 2018;15(2):136–46. https://doi.org/10.1007/s11904-018-0383-2.
Comments (0)